One Platform

Enables Rational PIC Design

CelerisTx One

CelerisTx One

PIC Design

Xanthos is the platform’s design engine. Starting with a protein target sequence, we determine 3D structures, predict ligand binding, generate linkers, predict ternary complexes and refine PIC selection through several layers of filters including molecular dynamics and QSAR. 

From Data to Hit

Automated Synthesis Lab

Hephaistos is the platform’s synthesis engine. Machine learning-driven retrosynthesis and a robotized synthesis lab create real-world, custom chemical matter for testing in our automated biology lab (Hades). Our facility includes all necessary organic synthesis equipment, such as fume hoods, evaporators, HPLC, LC-MS and microfluidic synthesis.

From Hit to Compound

Biological Validation

Hades is the platform’s biological information engine. It generates experimental data obtained from our automated lab which we began constructing mid 2021. We exploit several, different biochemical assays and phenotypic screening protocols, and have in-house capabilities in cell culture, high-content imaging, functional assays and molecular biology.

From Compound to Lead

The PIC Engineering Company

We are CelerisTx

We are an international team of highly skilled experts from disciplines as computational chemistry, medicinal chemistry, biology and machine learning.

Our team is complemented by highly esteemed advisors and investors at the intersection of artificial intelligence and life sciences.

One Team. One Vision.


Christopher Trummer

CEO, President and Co-Founder

Jakob Hohenberger

CFO/COO, Director and Co-Founder

Dr. Chris Tame

VP, Head of Drug Discovery and London Office


Dr. James Field


Karel Kubias


Dr. Peter Ho


Petr Šrámek

Observer and Advisor

Dr. Ronjon Nag

Observer and Advisor

Scientific Advisors

Dr. John Harling

Former Senior Scientific Director at GSK

Prof. Dr. Jean-Louis Reymond

Former Dir. of Chemistry and Biochemistry at the University of Bern.

Assoc.-Prof. Dr. Johannes Kirchmair

Head of Comp. Drug Discovery and Design at the University of Vienna.

Prof. Dr. Ola Spjuth

Professor at the University of Uppsala.

Open positions

Go to Careers to view the open positions.

Our Investors

Our Supporters